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Research
AbstrACt
Objectives To assess the feasibility of delivering and 
evaluating a weight management (WM) programme for 
overweight patients with a family history (FH) of breast 
cancer (BC) or colorectal cancer (CRC).
study design A two-arm (intervention vs usual care) 
randomised controlled trial.
setting National Health Service (NHS) Tayside and NHS 
Grampian.
Participants People with a FH of BC or CRC aged≥18 
years and body mass index of ≥25 kg/m2 referred to NHS 
genetic services.
Intervention Participants were randomised to a control 
(lifestyle booklet) or 12-week intervention arm where they 
were given one face-to-face counselling session, four 
telephone consultations and web-based support. A goal of 
5% reduction in body weight was set, and a personalised 
diet and physical activity (PA) programme was provided. 
Behavioural change techniques (motivational interviewing, 
action and coping plans and implementation intentions) 
were used.
Primary outcome Feasibility measures: recruitment, 
programme implementation, fidelity measures, achieved 
measurements and retention, participant satisfaction 
assessed by questionnaire and qualitative interviews.
secondary outcomes Measured changes in weight and 
PA and reported diet and psychosocial measures between 
baseline and 12-week follow-up.
results Of 480 patients approached, 196 (41%) 
expressed interest in the study, and of those, 78 (40%) 
patients were randomised. Implementation of the 
programme was challenging within the time allotted 
and fidelity to the intervention modest (62%). Qualitative 
findings indicated the programme was well received. 
Questionnaires and anthropometric data were completed 
by >98%. Accelerometer data were attained by 84% and 
54% at baseline and follow-up, respectively. Retention at 
12 weeks was 76%. Overall, 36% of the intervention group 
(vs 0% in control) achieved 5% weight loss. Favourable 
increases in PA and reduction in dietary fat were also 
reported.
Conclusions A lifestyle programme for people with 
a family history of cancer is feasible to conduct and 
acceptable to participants, and indicative results suggest 
favourable outcomes.
trial registration number ISRCTN13123470; Pre-results.
IntrOduCtIOn 
It is recognised that cancer arises from an inter-
action between genetic and environmental 
factors (nature and nurture), although there 
may be more emphasis given to genetics and 
family history in the National Health Service 
(NHS) rather than health behaviour profiles. 
Clearly, it is desirable that people who are 
at greater risk of cancer due to a family 
history of the disease (which may reflect 
shared genetic and behavioural profiles) are 
supported to follow recommendations for 
strengths and limitations of this study
 ► This feasibility study is the first attempt to offer 
and assess a structured, comprehensive lifestyle 
programme (diet, alcohol, physical activity and body 
weight) for people referred to family history clinics 
for colorectal and breast cancer risk assessment.
 ► The study design is a randomised, two-centred, 
lifestyle intervention study with subjective and 
objective assessment measures.
 ► Participants were all attendees at the National Health 
Service Family History clinics due to a family history 
of breast cancer (BC) or colorectal cancer (CRC) and 
are not representative of the general population.
 ► The lifestyle intervention was not fully implemented, 
recruitment was lower than anticipated and 
indicative findings suggest favourable effects of the 
intervention on physiological measures.
 ► The primary and secondary outcome data provide 
sufficient information to inform a definitive trial.
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cancer surveillance and lifestyle. NHS genetics centres in 
Scotland offer early detection and counselling for people 
with a family history (FH) of breast cancer (BC) and 
colorectal cancer (CRC),1 but there is little evidence of 
lifestyle advice.
Current estimates for the role of lifestyle in postmeno-
pausal BC suggest that around 38% of the disease could 
be prevented by increased physical activity and decreases 
in alcohol intake and excess body weight.2 A number 
of studies show that BC risk is lowered with intentional 
weight loss3 4 and recent data from bariatric surgery5 show 
that weight loss is correlated with significant decreases in 
the incidence of cancers at several sites—notably post-
menopausal breast, colon, endometrium and pancreas. 
Gramling et al6 reported from the Women’s Health Initia-
tive Observational study that participating in healthy life-
styles (greater physical activity, lower alcohol intake and 
lower body mass index (BMI)) led to risk reduction in 
postmenopausal women, and the degree of this benefit 
was the same for women with and without an FH of BC. A 
recent review by Pettapiece-Phillips et al7 reports evidence 
of a protective role of a healthy body size and regular 
activity among mutation carriers notably in adolescence 
and early adulthood.
It is estimated that around 45% of CRC could be 
prevented by diet and other lifestyle behaviours (dietary 
fibre intake and physical activity and low intakes of red 
and processed meat, alcohol and body fatness).2 For 
CRC, people with an FH may be more susceptible to life-
style-related risk. For example, in a pooled analysis, Cho 
et al8 reported that the relative risks of CRC with alcohol 
consumption of ≥30 g/d were 1.23 (95% CI 0.96 to 1.57; 
Not Significant) among those with no FH and 2.02 (95% 
CI 1.30 to 3.13) among those with an FH of CRC. The 
importance of excess weight and increased risk of devel-
oping CRC has been highlighted by Movahedi et al,9 who 
reported that in patients with Lynch syndrome, CRC risk 
was increased by 7% for each 1 kg/m2 increase in BMI. 
A recent review of alcohol, obesity and other nutritional 
factors in people with familial CRC by Fardet et al10 
present a clear case for why modifiable risk factors could 
offer new perspectives on prevention.
Akhtar et al11 reported, in a UK survey of relatives of 
patients diagnosed with CRC, that most (88%) said they 
were prepared to make lifestyle changes if given enough 
information. In the BeWEL12 study (lifestyle interven-
tion for people at higher CRC risk due to an adenoma), 
around half (49%) of 997 patients showed an interest in 
finding out more about the lifestyle (weight loss) trial.
It is also noteworthy that, for patients subsequently 
diagnosed with BC or CRC, obesity is associated with 
poorer prognosis, increases in disease recurrence and 
overall mortality.13 14
Identifying increased risk of developing a disease is 
unlikely to be sufficient to change behaviour,15 and knowl-
edge of FH per se is unlikely to be sufficient to initiate 
sustained weight management behaviours. In a question-
naire study of 237 (49%) people attending family history 
clinics in the East of Scotland, Anderson et al16 reported 
that while smoking rates were modest (11%), most 
respondents had a BMI ≥25 kg/m2, low levels of physical 
activity and high alcohol consumption. Interview data 
in a subgroup of these respondents highlighted doubts 
about the link between lifestyle and cancer, and few were 
familiar with the current evidence. While lifestyle advice 
was considered interesting in general, there was little 
appetite for non-tailored guidance.
Marteau and Lerman17 argues that motivation to 
change behaviour may be achieved by increasing beliefs 
that changing behaviour can reduce risks by increasing 
beliefs in the individual’s ability to change. However, it 
is more likely that self-efficacy and self-regulatory tech-
niques (eg, goal setting) play a greater role in achieving 
effective behaviour change.18 19 National Institute for 
Health and Care Excellence guidelines on familial BC 
recommend that standard written information for people 
with concerns about familial BC risk should include ‘life-
style, including diet, alcohol etc’,20 but the reasons for 
this choice of communication is unclear. Genetic coun-
sellors (GCs) receive little if any training in promoting 
healthy lifestyles, and there is little evidence that advice is 
routinely provided.
This study aimed to assess the feasibility and accept-
ability of delivering a 12-week lifestyle intervention 
programme (LivingWELL) for people with an FH of 
BC and CRC initiated within the FH setting in order to 
inform the design of a definitive randomised controlled 
trial (RCT) to assess the clinical and cost-effectiveness of 
this intervention.
Specific objectives were to estimate recruitment rate for 
a full RCT, assess the feasibility of data collection proce-
dures and protocol adherence, explore participant expe-
rience and establish a power calculation required for a 
full-scale study
MethOds
study design and setting
This study was a two-arm, two-centre, parallel, 
randomised-controlled, feasibility study integrated with 
qualitative interviews conducted with people referred 
to NHS genetic services in Tayside and Grampian from 
August 2015 to March 2016. This study is reported in 
accordance with the Consolidated Standards of Reporting 
Trials 2010 statement: extension to randomised pilot and 
feasibility trials.21
sample size
We aimed to recruit 120 (60 intervention and 60 control) 
participants in order to be able to assess feasibility objec-
tives allowing for a loss to follow-up of 10% with precision 
of ±1% at 95% CI.22
recruitment and randomisation
New attendees at genetics clinic were informed about 
the study by the GCs and given a brief information sheet, 
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clinician endorsement letter, non-participation question-
naire and reply slip with stamped addressed envelope. 
They were also offered the opportunity to discuss the 
study with the research team. Where low-risk patients did 
not attend the clinics in person, postal versions of the 
study materials were sent. Low initial recruitment after 3 
months resulted in a protocol amendment to allow study 
information to be passed to established patients returning 
for mammographic or endoscopic procedures in one 
centre (not considered feasible in the other centre).
GCs/clinical staff recorded the numbers of patients 
attending clinics and informed patients with an FH of BC 
or CRC about the study. Staff noted when they felt it inap-
propriate to provide information about the study and 
recorded any reasons that patients gave for non-partici-
pation. Interested patients were given a brief information 
sheet and an endorsement letter from the relevant lead 
clinician. They were asked to provide their contact details. 
An opt-out slip and non-participant feedback form were 
included for those who decided not to participate.
Research nurses made contact with interested 
patients to assess eligibility and provide a full informa-
tion sheet. All those written to (or given packs) could 
also respond by telephone/postal reply slip. Eligible 
participants were adults, age ≥18 years, with an FH of 
BC or CRC and measured BMI ≥25 kg/m2. Exclusion 
criteria were severe cognitive impairment, or conditions 
where physical activity was contraindicated, pregnancy, 
breast feeding or currently undergoing active treatment 
for cancer.
Once continued interest and eligibility were established, 
an appointment was made for a baseline measurement 
visit where informed consent was obtained. Postbaseline 
visit, participants were allocated (by the study admin-
istrator who informed the participant and lifestyle 
coach (LC) of the outcome) into usual care (control) 
or intervention groups 1:1 using a computer-generated 
random allocation list. The research nurse was blinded to 
the randomisation.
Figure 1 Intervention components (face-to-face visits). BHF, British Heart Foundation.
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Intervention
The 12-week intervention, ‘LivingWELL’, aimed to help 
participants increase physical activity, modify diet, achieve 
weight loss towards 5% of body weight and avoid weight 
gain. Personalised advice was given on a 600 kcal deficit 
dietary intake as recommended by the Scottish Intercol-
legiate Guidelines Network (SIGN)23 and a graduated 
approach aimed at increasing activity to 225–300 min 
per week by 12 weeks. The theoretical basis for the inter-
vention draws on Leventhal’s Self-Regulatory Theory24 
(which highlights the importance of the individual’s 
beliefs regarding illness cause, identity, control/cure, 
timeline and consequences), Social Cognitive Theory,25 
which emphasises the importance of self-efficacy, and the 
Health Action Process Approach,26 which emphasises the 
importance of action and coping planning.
The ‘LivingWELL’ programme was delivered by LCs 
personnel (with a nursing background) who received 
bespoke training on the delivery of the intervention 
programme. Intervention participants received one 
face-to-face session plus (up to) four telephone consul-
tations over the 12-week programme, a ‘LivingWELL’ 
information pack, pedometer and walking programme. 
Participants were also offered a web-based support 
programme. The face-to-face session was designed to 
be interactive and included a 10 min ‘walk and talk’ 
session during which pedometer use and walking goals 
were discussed, self-identification of BMI category and a 
portion weight estimate task.
Participants received a personalised energy deficit diet, 
a personalised graduated walking plan and guidance on 
setting personal goals, how to make changes habitual and 
relapse prevention strategies for times of deviation.
Motivational interviewing techniques were used to 
explore self-assessed confidence to change and self-per-
ceived benefits. Behavioural change techniques (goal 
setting, action and coping plans and implementation 
intentions) were also used. The importance of self-mon-
itoring pedometer data, diet and drink logs and weekly 
body weight was emphasised. These data formed the 
Figure 2 Intervention components (telephone calls).
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basis for the 15 min phone consultations, which checked 
well-being, self-monitoring behaviours, actions and 
coping plans. Details of the intervention are described in 
figures 1 and 2.
Primary outcome measure
Data were collected on numbers of people told about 
the study, those expressing an interest, numbers meeting 
eligibility criterion, rates of recruitment, achieved 
measurements and retention. Reasons for non-participa-
tion and withdrawal were collected where possible.
Intervention contact time was recorded by LCs, and 
the ease of implementing the counselling sessions and 
perceived engagement and motivation of participants was 
recorded using a 5-point Likert scale (scored −2 to +2). 
A random sample of face-to-face visits and telephone 
calls were recorded and independently analysed to assess 
fidelity to the detailed intervention protocol.
Table 1 Demographic characteristics at baseline
Intervention
(n=39)
Control
(n=39)
All
(n=78)
Age (years) mean 49.1±12.7 45.1±12.8 47.1±12.8
Range 22–72 18–71 18–72 
Gender  
  Male 6 (15) 3 (8) 9 (12) 
  Female 33 (85) 36 (92) 69 (88) 
Marital status  
  Single 3 (8) 8 (20.5) 11 (14) 
  Married/cohabiting 32 (82) 24 (61.5) 56 (72) 
  Divorced/widowed/separated 4 (10) 7 (18) 11 (14) 
Ethnicity 
  White 38 39 77
  Other 1 0 1
Highest educational qualification  
  Secondary school 15 (38.5) 11 (28) 26 (33) 
  Other professional/technical  qualification after school 9 (23) 15 (39) 24 (31) 
  University/postgraduate degree 15 (38.5) 13 (33) 28 (36) 
Employment status  
  Retired 9 (23) 4 (10) 13 (17) 
  Employed full-time 20 (51) 17 (44) 37 (48) 
  Employed part-time 5 (13) 8 (20) 13 (17) 
  Unemployed 2 (5) 3 (8) 5 (6) 
  Other 2 (5) 3 (8) 5 (6) 
  Student 1 (3) 4 (10) 5 (6) 
SIMD (quintiles)  
  1 (most deprived) 4 (11) 8 (20.5) 12 (15) 
  2 6 (16) 3 (8) 9 (12) 
  3 10 (26) 7 (18) 17 (22) 
  4 11 (29) 8 (20.5) 19 (25) 
  5 (least deprived) 7 (18) 13 (33) 20 (26) 
  Missing 1 0 1
Type of cancer*  
  Breast 24 (62) 27 (69) 51 (65) 
  Colorectal 15 (38) 12 (31) 27 (35) 
*Cancer family history, which resulted in a genetics referral.
All results are n (%) unless stated otherwise.
SIMD, Scottish Index of Multiple Deprivation.
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All participants who completed the study were asked to 
fill out an anonymous patient satisfaction questionnaire 
(to rate programme visits, measurements and interven-
tion) that was distributed after the follow-up visit. Qualita-
tive interviews (n=20) explored intervention participants’ 
views on study acceptability (recruitment, assessment and 
intervention programme) and factors influencing adher-
ence. Interviews were audio recorded, transcribed and 
analysed using a thematic framework approach.
secondary outcome measures
Follow-up procedures took place after the 12-week inter-
vention period. Both baseline and follow-up measures 
were undertaken by research nurses blinded to the group 
allocation, and participants were asked not to share their 
group allocation with the researchers.
Research nurses recorded sociodemographic informa-
tion and measured height at the baseline visit. At both 
baseline and follow-up, physiological measures (body 
weight, waist circumference and blood pressure) were 
taken, and BMI was assessed.
Physical activity was subjectively assessed using the Inter-
national Physical Activity Questionnaire Short Form27 
(for low/medium and high activity grading and to get 
insight into activity modes) and objectively measured by 
Sensewear (BodyMedia, Pittsburgh, Pennsylvania, USA) 
physical activity monitors, which provided detailed anal-
ysis of sedentary time, moderate and vigorous activity and 
step counts. Eating habits were assessed by the Dietary 
Instrument for Nutrition Education questionnaire28 and 
alcohol intake by a 7-day alcohol record.29 Smoking was 
assessed by questions on current and historic tobacco use.
Psychosocial variables measured included beliefs about 
cancer cause and risk reduction (modified brief illness 
perception questionnaire30) and quality of life using 
the Euro-Qol-5D questionnaire.31 These measures were 
undertaken primarily to assess participant burden for 
planning a full-scale trial.
statistical analysis
For all quantitative outcome measures, the main aim of 
this study was principally to assess feasibility of intervention 
Figure 3 CONSORT diagram ‘LivingWELL’ total recruitment. CONSORT, Consolidated Standards of Reporting Trials. 
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delivery to inform the design of a main trial, thus the indica-
tive outcomes are underpowered for statistical interpretation.
Quantitative data analysis was undertaken using STATA 
V.14. Descriptive statistics were used to characterise the 
cohort. Within group changes between baseline and 
follow-up outcomes were estimated for intervention and 
control groups using a paired t-test. Between group differ-
ences in the outcome change from baseline and follow-up 
adjusted for baseline values were estimated using linear 
regression methods. Both within and between group 
differences are presented as means and 95% CIs.
results
Primary outcomes (feasibility)
Patients informed about the study
In total, 600 patients were identified as potentially eligible 
for the study (364 BC and 236 CRC FH) over the 8-month 
recruitment period (figure 3). Of those, 312 (52%) were 
new patients and 288 (48%) review patients (4 month period 
only). Records kept by clinical and study staff show a total 
of 480 patients (282 BC and 198 CRC FH) were given study 
information (169 in person and 311 by invitation letters). 
Within the clinics, 120 people were not approached where 
GCs considered it inappropriate (35), the person was 
thought to be ineligible (46), there was not enough time (9), 
patients were in another study (2), staff noted they lived far 
from the hospital (7) or for reasons unknown (21).
Patients interested in the study
A total of 196 (41%) people (132 BC and 64 CRC FH) 
agreed to be contacted. Greatest interest in the study 
was expressed by new and review patients advised about 
the study in face-to-face clinic visits (70% and 93%, 
respectively, agreed to be contacted) compared with 
new and review patient advised by letter (7% and 27%, 
respectively). It is notable that despite the high interest 
expressed by review patients in face-to-face visits (93%), 
the numbers randomised dropped to 32%. No new 
patients contacted by letter went on to be randomised.
Eligibility and recruitment rate
Of the 196 who agreed to be contacted, 32 (16%) 
declined to take part, 40 (20%) did not respond to tele-
phone approaches and 46 (23%) were ineligible (due to 
BMI). A total of 78 people (40% of those who agreed to be 
contacted; 39% of BC and 42% of CRC FH approached; 
16% of those who were potentially eligible for the study) 
were randomised.
Baseline characteristics
The mean age was 27.1+12.8 years (range 18–72) and 
88% were female (table 1). Most were in employment, 
had postschool professional or academic qualifications 
and belonged to the two least deprived quintiles of the 
Scottish Index of Multiple Deprivation (SIMD).
Achieved measurements
Evaluation measures were 99%–100% complete for 
all participants who attended baseline and follow-up 
appointments. Accelerometer data (for at least 4 days) 
was obtained for 67 (84%) participants at baseline and 42 
(54%) at follow-up.
Retention
Of the 78 randomised, 59 (75%) completed the study 
(74% control and 77% intervention). Completion rates 
were similar by BC (72%) and CRC (81%) (figure 3). A 
greater proportion of people from SIMD quintiles 1 and 
2 (high deprivation) were likely to withdraw compared 
with SIMD quintiles 3, 4 and 5 (38% vs 22%).
Non-participation
It is estimated that approximately 100 non-participation 
feedback forms were distributed at clinic appointments, 
and over 300 were posted with study information packs. A 
Table 2 Changes in physiological measures
Intervention Control
Between group 
differences
Mean (95% CI)n Mean (SD)
Difference to 
baseline
Mean (95% CI) n Mean (SD)
Difference to 
baseline
Mean (95% CI)
Bodyweight (kg)
Baseline 39 90.9 (17.0)
−3.2 (1.5 to 4.8)
39 88.2 (15.9)
−0.3 (−0.4 to 1.0) 2.8 (1.1 to 4.6)12 weeks 30 85.9 (16.3) 29 87.6 (15.6)
Body mass 
index (kg/m2)
Baseline 39 33.1 (6.3)
−1.1 (0.5 to 1.7)
39 32.3 (5.2)
−0.1 (−0.1 to 0.3) 1.0 (0.4 to 1.7)12 weeks 30 31.6 (6.2) 29 31.9 (5.0)
Waist 
circumference 
(cm)
Baseline 39 102.4 (12.9)
−5.0 (3.3 to 6.8)
39 101.2 (13.8)
−0.8 (−1.0 to 2.5) 4.2 (1.8 to 6.7)12 weeks 30 96.3 (14.5) 29 99.7 (14.2)
Mean systolic 
blood pressure 
(mm Hg)
Baseline 39 139.5 (18.9)
−10.6 (5.6 to 15.7)
39 134.5 (13.6)
−4.5 (−0.1 to 9.1) 4.5 (−1.0 to 10.1)12 weeks 30 129.7 (11.8) 29 132.6 (14.4)
Mean diastolic 
blood pressure 
(mm Hg)
Baseline 39 84.3 (10.4)
−2.9 (0.5 to 5.3)
39 82.1 (9.4)
−0.7 (−1.6 to 3.0) 1.9 (−1.0 to 4.8)12 weeks 30 81.6 (8.0) 29 82.8 (8.5)
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total of 28 questionnaires were returned. Most responders 
were women (86%), and the average age was 51.2 years 
(range 25–72). Of those, 21 people reported a weight and 
height: 9 had a normal BMI and 12 were overweight or 
obese. The majority of respondents were from areas of 
low deprivation (59%). The most common reasons for 
not taking part were that ‘their lifestyle was already good’ 
(29%) and ‘too little time to participate’ (14%).
Intervention contact and delivery
In the intervention group, 37 of the 39 randomised (two 
withdrew) received a face-to-face session with a LC. The 
mean time for the face-to-face visit was 81 min (range 
70–130) compared with an estimated 65 min. The mean 
time for telephone calls at all time points was 15 min 
(range 5–30), the same as the estimated allowance.
The LCs estimated around 73% of the total programme 
was covered, while fidelity scores for nine face-to-face 
sessions and that 16 telephone calls rated that 62% of the 
intervention components were delivered as per protocol. 
LCs assessed perceived patient engagement, receptivity 
and motivation highly: 89%, 92%, and 89% respectively, 
in Likert-scaled questions.
Access to the ‘LivingWELL’ study website was given to 
all intervention participants and 10 (33%) logged on.
Participant feedback
Acceptability data were obtained from 47 (80%) anony-
mised patient satisfaction questionnaires (23 control and 
24 intervention) and from the 20 participant interviews. 
Results from the questionnaire showed that most (89%) 
participants reported that they found study participation 
quite/very easy and 38 (81%) reported that they would 
recommend ‘LivingWELL’ to others. Most (80%) of the 
intervention group expressed a high degree of satisfac-
tion with intervention components. The following sugges-
tions for change were made: feedback of results, further 
contacts with coaches and longer term follow-up.
The qualitative interview data revealed that interven-
tion staff were perceived by participants as professional, 
knowledgeable, helpful and approachable. Appoint-
ments at the centre with LCs were largely perceived as 
convenient in terms of duration, scheduling and travel 
incurred. The various measurements were not considered 
invasive or inappropriate. However, a few participants 
found the activity monitors heavy and uncomfortable. 
Overall, most participants were satisfied with the study 
and recommended few improvements. Participants 
reported the following barriers to change:
 ► everyday routines
 ► sedentary occupations
 ► family commitments
 ► poor physical or mental health
 ► stressful events such as exams, bereavement or family 
illness
 ► long-standing complex relationships with food.
In general, participants appeared to find it easier to 
change physical activity than diet.
secondary outcomes
The aim of this study was to determine feasibility, not to 
evaluate statistically significant change. However, changes 
in physiological measures suggest a favourable effect of 
the intervention on the primary outcome of body weight 
loss and diastolic blood pressure (table 2). These find-
ings are reflected in the proportions achieving 5% weight 
loss (37% in the intervention group compared with 0% 
in control group) and 10% weight loss (10% of the inter-
vention group).
Favourable increases in moderate physical activity (from 
objective accelerometer data) and decreases in dietary fat 
scores were also reported (tables 3 and 4). Little change 
was observed in reported alcohol intake.
Using the data from the current study, where we 
observed a mean body weight of 89.5 kg (±SD 13.3), a 
total of 187 participants per group would be needed to 
detect a between group difference of 5% weightt change 
(4.47 kg) at follow-up, at 90% power and 5% alpha based 
on a two-tailed unpaired t-test. Allowing for an assumed 
25% drop-out this would mean recruiting 250 partici-
pants per group.
Based on the current figures: to recruit 500 people, 
1250 would need to express an interest (40% of those 
Table 3 Changes in physical activity
Intervention Control
Between group 
differences
Mean (95% CI)n Mean (SD)
Difference to 
baseline
Mean (95% CI) n Mean (SD)
Difference to 
baseline
Mean (95% CI)
Daily average 
time spent in 
moderate activity 
(min)
Baseline 34 58.1 (49.5)
20.3 (−36.2 to −4.4)
38 60.3 (39.4)
5.82 (−27.2 to 15.5) −13.6 (39.0 to 11.7)12 weeks 23 86.8 (62.0) 23 73.2 (46.5)
Daily average 
time spent in 
vigorous activity 
(min)
Baseline 34 1.1 (2.8)
0.1 (−1.2 to 1.0)
38 1.5 (3.5)
−0.5 (−1.3 to 2.3) 1.0 (−3.0 to 1.0)12 weeks 23 1.0 (2.1) 23 1.2 (3.3)
Daily average 
step count
Baseline 34 7544 (3738)
1760 (−3111 to −408)
38 7999 (3937)
699 (−2629 to 1230) 939 (−3187 to 1309)12 weeks 23 10 315 (5551) 23 9468 (3793)
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who expressed an interest were recruited). For 1250 to 
express an interest, 3048 would require to be approached 
(based on 41% of people approached were interested). 
If all clinics recruited similar numbers to the two in the 
current study (240 in an 8-month period/360 per year), 
then nine centres would be needed for a 12-month 
recruitment period.
dIsCussIOn
Main findings
Despite evidence for the importance of lifestyle in the 
aetiology of BC and CRC, counselling on diet, physical 
activity and weight management is not routinely provided 
for people with a family history of these conditions 
referred to NHS genetics clinics. While cancer prevent-
ability estimates suggest that healthful ways of life could 
significantly reduce cancer risk, the impact of lifestyle 
interventions in this patient group is unknown and 
randomised controlled trial data is needed to examine 
the cost, benefits and harms. The results from this pilot 
study show that it is feasible to recruit, randomise and 
retain patients and to implement and evaluate a weight 
management programme combining diet and physical 
activity advice with behavioural change techniques that 
is acceptable to patients. The results also indicate that 
implementation of this programme is associated with 
favourable outcomes. However, the current work has 
highlighted the importance of face-to-face approaches 
for study recruitment and the cautious approach taken 
by genetic clinic staff to introducing the study. The find-
ings have also enabled the collection of data that allows 
a power calculation to be performed for the design of a 
definitive randomised controlled trial.
strengths and weaknesses
The main strength of the study is that (to the best of our 
knowledge) the current work is the first attempt to offer 
a comprehensive lifestyle programme (diet, alcohol, 
physical activity and body weight) for people referred 
to FH clinics for CRC and BC risk assessment. The main 
weakness of the study is the sociodemographic profile of 
participants recruited who were predominantly Cauca-
sian and >50% were from the two lowest deprivation 
quintiles (eg, higher socioeconomic status). Although 
this distribution reflects the general demographic for 
high-risk attendees for breast mammography clinics in 
this region32 (where there is little ethnic diversity), it 
highlights the difficulties in offering both surveillance 
and lifestyle interventions to affected people from more 
deprived areas.
The sample size was less than planned due to fewer 
patients being referred to the service than previous years 
(on which our estimate was based), fewer informed about 
the study than estimated (despite input from clinic staff in 
study design) and fewer being seen face to face than antic-
ipated. The current results underline the need for feasi-
bility work. Overall, study retention was high but further 
efforts to reduce loss to follow-up in people living in areas 
of higher deprivation should be explored. Attempts to 
increase recruitment from existing patients demonstrate 
that both new and returning patients have some interest 
in the topic, but in general a greater awareness of the rele-
vance of lifestyle in cancer prevention would be beneficial 
to recruitment. Other weaknesses include the time allo-
cation for the face-to-face meeting, which was insufficient 
for the intended content, resulting in the LCs deviating 
from the original protocol. In addition, retention was only 
assessed over a 12-week period, and a longer test period 
is likely to be associated with higher loss to follow-up. 
Independent assessment of fidelity also suggests scope for 
improvement in time allocation as only 62% of interven-
tion components were delivered per protocol.
Other studies
No fully powered trials of lifestyle interventions in people 
with family history of cancer have yet reported and 
those that have been described in the literature focus 
primarily on physical activity33 34 in Breast Cancer, early 
onset (BRCA) mutation carriers. Ongoing trials of weight 
management to decrease BC risk are being undertaken 
in women already diagnosed with the disease35–38 but are 
not exclusive to people at increased genetic risk. Pilot and 
Table 4 Changes in dietary intake scores
Intervention Control
Between group 
differences
Mean (95% CI)n Mean (SD)
Difference to 
baseline
Mean (95% CI) n Mean (SD)
Difference to 
baseline
Mean (95% CI)
Fat 
consumption 
score
Baseline 39 29.3 (9.0)
−7.8 (5.2 to 10.4)
39 28.6 (9.3)
−1.2 (−1.5 to 4.0) 6.6 (3.7 to 9.5)12 weeks 30 20.5 (6.0) 29 27.2 (7.6)
Unsaturated 
fat score
Baseline 39 8.3 (1.4)
−0.2 (−0.4 to 0.7)
39 8.2 (1.2)
0.2 (−0.7 to 0.4) 0.3 (−0.4 to 1.0)12 weeks 30 8.2 (1.7) 29 8.4 (1.4)
Fibre food 
consumption 
score
Baseline 39 31.7 (11.5)
0.6 (−4.4 to 3.2)
39 29.6 (9.2)
−0.8 (−2.5 to 4.0) 1.8 (−6.2 to 2.6)12 weeks 30 32.5 (10.9) 29 30.1 (9.4)
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formative work on weight loss and reducing markers of 
BC has been undertaken39 (notably on the intermittent 
energy diet approach) in women with family history of BC, 
demonstrating significant changes in insulin sensitivity 
and body fat reduction, but no work has been reported 
for patients with a family history of CRC. Postintervention 
interviews with participants40 have highlighted the impor-
tance of providing a credible rationale for weight control 
and weight loss that underlines the need for health profes-
sionals working in this area to introduce and endorse the 
importance of lifestyle to aid recruitment.
Implications for clinicians and policymakers
This pilot study has highlighted a number of perceived 
challenges for NHS staff discussing lifestyle issues among 
patients with a family history of BC and CRC but has also 
demonstrated that there is an interest in being able to 
offer more help that could usefully be developed. Indica-
tive results suggest the intervention had a favourable effect 
on body weight, physical activity and fat intake score with 
potential for clinically relevant benefits for both cancer 
risk reduction and long-term health (with or without a 
cancer diagnosis). While the qualitative data highlight the 
complexity and challenge of changing health behaviours, 
the measured changes in physical activity and weight 
loss suggest that small but significant changes can be 
achieved, at least in the short term. Support for habitual 
and sustained lifestyle change is essential as part of long-
term intervention design.
unanswered questions and future research
The generalisability of the current findings are unclear. 
However, work to date suggests that the intervention is 
feasible to deliver and evaluate and could be tested in a 
large RCT, subject to modifications. In a fully powered 
trial, the first stage would be to assess the magnitude 
of lifestyle change that can be achieved by this type of 
programme. In turn, this fully powered trial would act 
as a ‘pilot’ for a full trial of reduction in CRC markers. 
Adenomas (number and size) might be an appropriate 
end point depending on funding for the length of 
follow-up.
It would be desirable to increase patient recruitment, 
and the current findings suggest that overall uptake could 
be increased with better training, support and endorse-
ment from the GCs and other clinical staff. This area of 
study was almost entirely new and met with scepticism 
from staff and indeed patients. Our earlier work suggests 
ambiguous attitudes about the importance of lifestyle 
with little evidence that these topics have been previously 
discussed with clinicians.18
The programme was received enthusiastically by partic-
ipants, but further work is needed to refine intervention 
components, particularly dietary aspects that were less 
appreciated than the physical activity aspects and may 
need tailoring for ethnic groups. Measurements were 
successfully attained and appropriate for a full study 
protocol, although a review of accelerometry approaches 
is warranted. The numbers required for a full trial with 
weight change as a primary outcome would require a 
multicentre approach with a minimum recruitment 
period of at least 12 months. Overall, the main uncer-
tainties required for planning a definitive randomised 
controlled trial have been addressed.
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